Diversity of penicillin-binding proteins. Resistance factor FmtA of Staphylococcus aureus

Xin Fan1, Yuhong Liu, Daryl Smith

  • 1Department of Chemistry, York University, Toronto, Ontario M3J 1P3, Canada.

Insights

FmtA, a protein in methicillin-resistant Staphylococcus aureus, interacts with beta-lactam antibiotics. This interaction suggests FmtA may be a penicillin-binding protein crucial for antibiotic resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Resistance

Background:

  • Antibiotic-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), poses a significant public health threat.
  • Penicillin-binding protein 2a (PBP2a) is a key factor in MRSA's resistance to beta-lactam antibiotics.
  • The roles of other proteins contributing to high-level MRSA resistance remain largely unknown.

Purpose of the Study:

  • To investigate the function of the FmtA protein in methicillin resistance in Staphylococcus aureus.
  • To elucidate the mechanism by which FmtA interacts with beta-lactam antibiotics.

Main Methods:

  • Biochemical assays to study the interaction between FmtA and beta-lactam antibiotics.
  • Analysis of the active-site serine residue and its role in complex formation.
  • Investigation of FmtA's binding affinity and acylation rate with beta-lactams.
  • Conformational change studies of FmtA in the presence of beta-lactams.
  • In vitro binding assays of FmtA to peptidoglycan.

Main Results:

  • FmtA forms covalently bound complexes with beta-lactam antibiotics.
  • A conserved serine residue in FmtA acts as the active-site nucleophile.
  • FmtA exhibits low binding affinity and slow acylation rates for beta-lactams, indicating intrinsic resistance.
  • Beta-lactam exposure induces conformational changes in FmtA.
  • FmtA demonstrates binding to peptidoglycan in vitro.

Conclusions:

  • FmtA is identified as a putative penicillin-binding protein.
  • FmtA's properties suggest it contributes to intrinsic beta-lactam resistance.
  • FmtA may play a role in compensating for peptidoglycan biosynthesis under cell wall stress induced by beta-lactams.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...